Receptor tyrosine-protein kinase erbB-2
CAT No: ta-344
Synonyms/Alias:Receptor tyrosine-protein kinase erbB-2 (754-762)
Receptor tyrosine-protein kinase erbB-2 (754-762) is a synthetic peptide fragment corresponding to amino acids 754 through 762 of the human HER2/neu (erbB-2) receptor tyrosine kinase. As a segment derived from a critical region of the HER2 protein, this peptide is of significant interest in signal transduction research, molecular oncology, and immunological studies. Its biochemical relevance stems from the role of the parent protein in cell proliferation, differentiation, and survival pathways, making it a widely studied target in cancer biology and receptor-mediated signaling investigations.
Epitope mapping: The erbB-2 (754-762) peptide is frequently utilized in epitope mapping experiments to identify and characterize antibody binding sites within the HER2/neu protein. By serving as a defined antigenic determinant, it enables researchers to assess the specificity and affinity of monoclonal or polyclonal antibodies developed against HER2. This application is particularly valuable for the development and validation of immunodetection reagents, as well as for dissecting the immune response to HER2 in various experimental models.
T-cell response studies: This peptide is instrumental in studies of antigen-specific T-cell activation, particularly within the context of tumor immunology. As a minimal epitope capable of being presented by major histocompatibility complex (MHC) molecules, it allows for the assessment of cytotoxic T lymphocyte (CTL) recognition and activity. Researchers employ this fragment in functional assays to investigate the cellular immune response to HER2-positive cells, facilitating the exploration of immune surveillance mechanisms and the identification of immunodominant regions.
Peptide-based assay development: The defined sequence of erbB-2 (754-762) makes it a useful tool in the design and optimization of peptide-based assays, such as enzyme-linked immunosorbent assays (ELISA) and peptide-MHC tetramer staining. By incorporating this peptide into assay platforms, scientists can quantitatively measure antibody or T-cell responses with high specificity. This capability is essential for translational studies aiming to monitor immune engagement or to validate the immunogenicity of candidate therapeutics targeting HER2.
Protein-protein interaction analysis: Researchers employ this peptide fragment to probe interactions between the HER2 protein and other cellular components, including adaptor proteins, kinases, or regulatory molecules. By using synthetic peptides in binding assays or pull-down experiments, it is possible to dissect the molecular determinants of HER2-mediated signaling pathways. Such studies contribute to a deeper understanding of the structural and functional relationships governing receptor tyrosine kinase activity.
Peptide synthesis and modification studies: The erbB-2 (754-762) fragment serves as a model substrate for investigating peptide synthesis techniques, post-translational modifications, and structure-activity relationships. Its defined sequence and relevance to a biologically significant protein provide a valuable framework for optimizing solid-phase peptide synthesis protocols or for exploring the effects of specific amino acid substitutions and chemical modifications on peptide function and recognition. These investigations advance both methodological development and the broader understanding of peptide-protein interactions in cellular signaling contexts.
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.